DASH-1 logo  

DASH trial - Desmopressin for reversal of Antiplatelet drugs in Stroke due to Haemorrhage

Amendments

« Back to main documents page

SA/01/19 and SA/02/19

PI change for C007: Royal Devon and Exeter Hospital (Wonford) and approval of day 90 follow-up postal form.

SA/03/19

Covers changes to approved protocol, information sheets, consent forms and GP letter.

MA/04/19

Covers changes consent forms and information sheets.

MA/05/20

Recruitment extended to 30 June 2020, follow-up extended to 30 September 2020.

MA/06/20

Recruitment extended to 31 December 2020, follow-up extended to 31 March 2021.

MA/07/21

Recruitment extended to 31 September 2021, follow-up extended to 30 December 2021.

SA/04/21

MA/08/21

Site C005: Derby, closed to recruitment on 30 September 2021.

MA/09/21

Recruitment extended to 31 March 2022, follow-up extended to 30 June 2022.

MA/10/22

Added Edoxaban and Lixiana to day 90 follow-up CRF.

MA/11/22

Site C009: Aberdeen Royal Infirmary, closed to recruitment after using their last IMP treatment pack on 29 December 2021.

MA/12/22

The approved protocol has been updated to include additional blood sample analyses that will be performed in Oxford.